{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:16:47Z","timestamp":1783397807256,"version":"3.54.6"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["22A-020-0100"],"award-info":[{"award-number":["22A-020-0100"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2025-25459357"],"award-info":[{"award-number":["RS-2025-25459357"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2021-NR058961"],"award-info":[{"award-number":["RS-2021-NR058961"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctro.2026.101197","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T16:23:38Z","timestamp":1779812618000},"page":"101197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study"],"prefix":"10.1016","volume":"59","author":[{"given":"Seok-Joo","family":"Chun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Hoon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0631-7549","authenticated-orcid":false,"given":"Chan Woo","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2106-6856","authenticated-orcid":false,"given":"Hong In","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyuck","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7248-3214","authenticated-orcid":false,"given":"Joo Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101197_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107516","article-title":"Medulloblastoma: Molecular understanding, treatment evolution, and new developments","volume":"210","author":"Liu","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"20","key":"10.1016\/j.ctro.2026.101197_b0010","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJMra2116344","article-title":"Brain tumors in children","volume":"386","author":"Cohen","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ctro.2026.101197_b0015","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1200\/JCO.20.01372","article-title":"Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial (SJMB03)","volume":"39","author":"Gajjar","year":"2021","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.ctro.2026.101197_b0020","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1200\/JCO.20.02730","article-title":"Children's oncology group phase III trial of reduced-dose and reduced-volume radiotherapy with chemotherapy for newly diagnosed average-risk medulloblastoma","volume":"39","author":"Michalski","year":"2021","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.ctro.2026.101197_b0025","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.3390\/cancers13235945","article-title":"Radiotherapy in medulloblastoma\u2014evolution of treatment, current concepts and future perspectives","volume":"13","author":"Seidel","year":"2021","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.ctro.2026.101197_b0030","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1470-2045(13)70449-2","article-title":"Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis","volume":"14","author":"Ramaswamy","year":"2013","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ctro.2026.101197_b0035","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S2352-4642(20)30246-7","article-title":"Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study","volume":"4","author":"Hill","year":"2020","journal-title":"The Lancet Child & Adolescent Health"},{"issue":"3","key":"10.1016\/j.ctro.2026.101197_b0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/cancers14030471","article-title":"Local and systemic therapy of recurrent medulloblastomas in children and adolescents: results of the P-HIT-REZ 2005 study","volume":"14","author":"Gaab","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctro.2026.101197_b0045","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ccell.2014.11.002","article-title":"Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease","volume":"27","author":"Hill","year":"2015","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.ctro.2026.101197_b0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MPH.0000000000000547","article-title":"Survival after relapse of medulloblastoma","volume":"38","author":"Koschmann","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101197_b0055","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1097\/MPH.0000000000001095","article-title":"Survival following tumor recurrence in children with medulloblastoma","volume":"40","author":"Johnston","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"issue":"13","key":"10.1016\/j.ctro.2026.101197_b0060","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1002\/cncr.24341","article-title":"High\u2010dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome","volume":"115","author":"Butturini","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2026.101197_b0065","doi-asserted-by":"crossref","unstructured":"Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Rotz SJ, Fraint E, Rangarajan HG, Auletta JJ: Effect of autograft CD34+ dose on outcome in pediatric patients undergoing autologous hematopoietic stem cell transplant for central nervous system tumors. Transplantation and cellular therapy 2023, 29(6):380. e381-380. e389.","DOI":"10.1016\/j.jtct.2023.03.024"},{"issue":"12","key":"10.1016\/j.ctro.2026.101197_b0070","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1001\/jamaoncol.2023.4437","article-title":"Sustained survival benefit in recurrent medulloblastoma by a metronomic antiangiogenic regimen: a nonrandomized controlled trial","volume":"9","author":"Peyrl","year":"2023","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101197_b0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11060-021-03842-3","article-title":"Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma","volume":"155","author":"Baroni","year":"2021","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ctro.2026.101197_b0080","article-title":"Surgical management of recurrent medulloblastoma: a scoping review","volume":"1(aop):1\u20137","author":"Fredricks","year":"2025","journal-title":"J Neurosurg Pediatr"},{"issue":"11","key":"10.1016\/j.ctro.2026.101197_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31960","article-title":"Re\u2010irradiation in Children with Recurrent Medulloblastoma","volume":"72","author":"\u0130riba\u015f \u00c7elik","year":"2025","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.ctro.2026.101197_b0090","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.3390\/cancers14112747","article-title":"Toxicity and clinical results after proton therapy for pediatric medulloblastoma: a multi-centric retrospective study","volume":"14","author":"Ruggi","year":"2022","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.ctro.2026.101197_b0095","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.3390\/jcm13123592","article-title":"The role of cyberknife stereotactic radiosurgery in recurrent cranial medulloblastomas across pediatric and adult populations","volume":"13","author":"Yoo","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ctro.2026.101197_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00381-025-06916-z","article-title":"Proton versus photon radiation therapy for pediatric medulloblastomas: a systematic review and meta-analysis","volume":"41","author":"Palavani","year":"2025","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ctro.2026.101197_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102469","article-title":"The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patients","volume":"69","author":"Keeling","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.ctro.2026.101197_b0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/02688691003660558","article-title":"Recurrence in medulloblastoma\u2013Influence of clinical, histological and immunohistochemical factors","volume":"24","author":"Srikantha","year":"2010","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.ctro.2026.101197_b0115","article-title":"Risk factors for survival in patients with medulloblastoma: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101197_b0120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00401-011-0918-8","article-title":"Biological and clinical heterogeneity of MYCN-amplified medulloblastoma","volume":"123","author":"Korshunov","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ctro.2026.101197_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.694320","article-title":"Biological role of MYCN in medulloblastoma: novel therapeutic opportunities and challenges ahead","volume":"11","author":"Shrestha","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101197_b0130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/neuonc\/noae178","article-title":"Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: a multicenter cohort study","volume":"27","author":"Schwalbe","year":"2025","journal-title":"Neuro Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2026.101197_b0135","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.3390\/cancers16111955","article-title":"Radiotherapy for Recurrent Medulloblastoma in Children and Adolescents: Survival after Re-Irradiation and First-Time Irradiation","volume":"16","author":"Adolph","year":"2024","journal-title":"Cancers"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:42:26Z","timestamp":1783395746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"alternative-id":["S2405630826000923"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101197","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101197"}}